Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells

Liga Saulite, Karlis Pleiko, Ineta Popena, Dominyka Dapkute, Ricardas Rotomskis and Una Riekstina
Beilstein J. Nanotechnol. 2018, 9, 321–332. https://doi.org/10.3762/bjnano.9.32

Supporting Information

Supporting Information File 1: Additional experimental information.
Endocytosis inhibitor assay; QD endocytic pathway analysis in MSCs, MCF7 and MDA-MB-231 cells; Confocal microscopy z-sections of MSC and breast cancer cell co-culture spheroids; EpCAM expression in MSCs and breast cancer cells MCF7 and MDA-MB-231; QD transfer from nanoengineered MSCs to MCF7 cells using EpCAM as a selective marker for MCF7 cells.
Format: PDF Size: 457.7 KB Download

Cite the Following Article

Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
Liga Saulite, Karlis Pleiko, Ineta Popena, Dominyka Dapkute, Ricardas Rotomskis and Una Riekstina
Beilstein J. Nanotechnol. 2018, 9, 321–332. https://doi.org/10.3762/bjnano.9.32

How to Cite

Saulite, L.; Pleiko, K.; Popena, I.; Dapkute, D.; Rotomskis, R.; Riekstina, U. Beilstein J. Nanotechnol. 2018, 9, 321–332. doi:10.3762/bjnano.9.32

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 445.4 KB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Karami Fath, M.; Bagherzadeh Torbati, S. M.; Saqagandomabadi, V.; Yousefi Afshar, O.; Khalilzad, M.; Abedi, S.; Moliani, A.; Daneshdoust, D.; Barati, G. The therapeutic effect of MSCs and their extracellular vesicles on neuroblastoma. Progress in biophysics and molecular biology 2024, 187, 51–60. doi:10.1016/j.pbiomolbio.2024.02.004
  • Ebrahimnejad, P.; Mohammadi, Z.; Babaei, A.; Ahmadi, M.; Amirkhanloo, S.; Asare-Addo, K.; Nokhodchid, A. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications. Critical reviews in therapeutic drug carrier systems 2024, 41, 35–84. doi:10.1615/critrevtherdrugcarriersyst.v41.i1.20
  • Farhoudi, L.; Fobian, S.-F.; Oei, A. L.; Amin, M.; Jaafari, M. R.; ten Hagen, T. L. Applications of biomimetic nanoparticles in breast cancer as a blueprint for improved next-generation cervical cancer therapy. Nano Today 2023, 53, 102032. doi:10.1016/j.nantod.2023.102032
  • Kheiri Yeghaneh Azar, B.; Nourbakhsh, M.; Nasiraee, M. R.; Mousavizadeh, K.; Madjd, Z.; Ajoudanian, M.; Saeedi, S.; Vahabi, A.; Hamblin, M. R.; Karimi, M. Combination of anti-miR19a-3p polyplex plus doxorubicin for breast cancer in 2D culture and apoptosis assay in 3D spheroids in a microwell device. Journal of Micromechanics and Microengineering 2023, 34, 15002–015002. doi:10.1088/1361-6439/ad0d7f
  • Steenbrugge, J.; Pauwelyn, G.; Demeyere, K.; Devriendt, N.; de Rooster, H.; Sanders, N. N.; Spaas, J. H.; Meyer, E. Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle. Frontiers in immunology 2023, 14, 1252374. doi:10.3389/fimmu.2023.1252374
  • Karami Fath, M.; Moayedi Banan, Z.; Barati, R.; Mohammadrezakhani, O.; Ghaderi, A.; Hatami, A.; Ghiabi, S.; Zeidi, N.; Asgari, K.; Payandeh, Z.; Barati, G. Recent advancements to engineer mesenchymal stem cells and their extracellular vesicles for targeting and destroying tumors. Progress in biophysics and molecular biology 2023, 178, 1–16. doi:10.1016/j.pbiomolbio.2023.02.001
  • Dai, X.; Zhu, K. Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting. Cancer medicine 2023, 12, 7189–7206. doi:10.1002/cam4.5491
  • Behl, A.; Chhillar, A. K. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer. Recent patents on anti-cancer drug discovery 2023, 18, 325–342. doi:10.2174/157489281703220610170559
  • Dirheimer, L.; Pons, T.; Marchal, F.; Bezdetnaya, L. Quantum Dots Mediated Imaging and Phototherapy in Cancer Spheroid Models: State of the Art and Perspectives. Pharmaceutics 2022, 14, 2136. doi:10.3390/pharmaceutics14102136
  • Wei, W.; Zhang, Y.; Lin, Z.; Wu, X.; Fan, W.; Chen, J. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review. Journal of drug targeting 2022, 31, 1–13. doi:10.1080/1061186x.2022.2104299
  • Gentile, P. Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research. Biomedicines 2022, 10, 1179. doi:10.3390/biomedicines10051179
  • Karimi-Shahri, M.; Javid, H.; Sharbaf Mashhad, A.; Yazdani, S.; Hashemy, S. I. Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend. Iranian journal of basic medical sciences 2021, 24, 1307.
  • Dapkute, D.; Pleckaitis, M.; Bulotiene, D.; Daunoravicius, D.; Rotomskis, R.; Karabanovas, V. Hitchhiking Nanoparticles: Mesenchymal Stem Cell-Mediated Delivery of Theranostic Nanoparticles. ACS applied materials & interfaces 2021, 13, 43937–43951. doi:10.1021/acsami.1c10445
  • Fu, H.; Wu, Y.; Yang, X.; Huang, S.; Yu, F.; Deng, H.; Zhang, S.; Xiang, Q. Stem cell and its derivatives as drug delivery vehicles: an effective new strategy of drug delivery system. All Life 2021, 14, 782–798. doi:10.1080/26895293.2021.1967202
  • Li, L.; Chen, T.; Yang, Z.; Chen, Y.; Liu, D.; Xiao, H.; Liu, M.; Liu, K.; Xu, J.; Liu, S.; Wang, X.; Lin, G.; Xu, G. Nephrotoxicity Evaluation of Indium Phosphide Quantum Dots with Different Surface Modifications in BALB/c Mice. International journal of molecular sciences 2020, 21, 7137. doi:10.3390/ijms21197137
  • Tosat-Bitrián, C.; Palomo, V. CdSe quantum dots evaluation in primary cellular models or tissues derived from patients. Nanomedicine : nanotechnology, biology, and medicine 2020, 30, 102299. doi:10.1016/j.nano.2020.102299
  • Heidari, R.; Dehkordi, N. G.; Mohseni, R.; Safaei, M. Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer. Journal of drug targeting 2020, 28, 732–741. doi:10.1080/1061186x.2020.1775842
  • Peydayesh, M.; Raisi, M.; Kaykavousi, K.; Gharaghani, M. A.; Abdollahpour-Alitappeh, M.; Mosazade, F.; Seifalian, A. M.; Khatami, M. The inhibitory effect of Tamarix hispida mediated silver nanoparticles on Cyclin D1 protein expression of human cancer cells line. Inorganic and Nano-Metal Chemistry 2020, 1–6.
  • Peydayesh, M.; Raisi, M.; Kaykavousi, K.; Gharaghani, M. A.; Abdollahpour-Alitappeh, M.; Mosazade, F.; Seifalian, A.; Khatami, M. The inhibitory effect of Tamarix hispida mediated silver nanoparticles on Cyclin D1 protein expression of human cancer cells line. Inorganic and Nano-Metal Chemistry 2020, 50, 1144–1149. doi:10.1080/24701556.2020.1735432
  • Ashrafizadeh, M.; Ahmadi, Z.; Kotla, N. G.; Afshar, E. G.; Samarghandian, S.; Mandegary, A.; Pardakhty, A.; Mohammadinejad, R.; Sethi, G. Nanoparticles Targeting STATs in Cancer Therapy. Cells 2019, 8, 1158. doi:10.3390/cells8101158
Other Beilstein-Institut Open Science Activities